Rotavirus vaccination in Brazil: Effectiveness and health impact seven years post-introduction

Expert Review of Vaccines

Volumn 13, Issue 1, 2014, Pages 43-57

  Linhares, Alexandre C ^a   Justino, Maria Cleonice A ^a  

^a INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

Brazil; effectiveness; gastroenteritis; genotypes; intussusception; rotavirus; vaccine impact; vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; ROTAVIRUS VACCINE;

AGE DISTRIBUTION; ATTRIBUTABLE RISK; BRAZIL; CASE CONTROL STUDY; CHILD HEALTH CARE; DIARRHEA; DRUG COST; DRUG SAFETY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEALTH IMPACT ASSESSMENT; HOSPITALIZATION; HUMAN; INTUSSUSCEPTION; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROGRAM EFFECTIVENESS; REVIEW; RISK BENEFIT ANALYSIS; ROTAVIRUS; ROTAVIRUS INFECTION; SEROTYPE; VACCINATION; VIRAL GASTROENTERITIS; VIRUS STRAIN; WORLD HEALTH ORGANIZATION;

BRAZIL; HEALTH POLICY; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INTUSSUSCEPTION; PREVALENCE; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SURVIVAL ANALYSIS; VACCINATION;

EID: 84893149048     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2014.861746     Document Type: Review

References (61)

1. Walker CL, Rudan I, Liu L et al. Global burden of childhood pneumonia and diarrhoea. Lancet 381(9875), 1405-1416 (2013).
2. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. WHO-coordinated Global Rotavirus Surveillance Network. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect. Dis. 12(2), 136-141 (2012).
3. Pe'rez-Schael I, O'Ryan M, Sa'ez-Llorens X et al. Clinical development, registration, and introduction of human rotavirus vaccine: the Latin American experience. Trials Vaccinol. 1(1), 10-20 (2012).
4. O'Ryan M, Lucero Y, Linhares AC. Rotarix-: vaccine performance 6 years postlicensure. Expert. Rev. Vaccines 10(12), 1645-1659 (2011).
5. Flannery B, Samad S, de Moraes, JC et al. Uptake of oral rotavirus vaccine and timeliness of routine immunization in Brazil's National Immunization Program. Vaccine 31(11), 1523-1528 (2013).
6. World Health Organization. Rotavirus vaccines. Wkly Epidemiol. Rec. 82(32), 285-295 (2007).
7. You D, Wardlaw T, Salama P, Jones G. Levels and trends in under-5 mortality, 1990-2008. Lancet 375 (9709), 100-103 (2010)
8. de Oliveira LH, Danovaro-Holliday C, Sanwogou NJ, Ruiz-Mathus C, Tambini G, Amdrus JK. Progress in the introduction of the rotavirus vaccine in Latin America and the Caribbean. Pediatr. Infect. Dis. J. 30(1), S61-S66 (2011).
9. de Oliveira LH, Toscano CM, Sanwogou NJ et al. Systematic documentation of new vaccine introduction in selected countries of the Latin America. Vaccine 31(Suppl. 3), C114-C122 (2013).
10. Leite JPG, Carvalho-Costa FA, Linhares AC. Group A rotavirus genotypes and the ongoing Brazilian experience -a review. Mem. Inst. Oswaldo Cruz 103(8), 745-753 (2008).
11. Linhares AC. A infecça?o por rotavi'rus no Brasil: epidemiologia e os desafios para o seu controle. Cad. Sau'de Pu'blica 16 (3), 629-646 (2000).
12. Pereira HG, Linhares AC, Candeias JAN, Glass RI. National laboratory surveillance of viral agents of gastroenteritis in Brazil. Pan. Am. J. Public Health 27(27), 21-28 (1993).
13. Brazilian Ministry of Health. Fundaçao Nacional de Saúde. Portaria No. 409, de de setembro de 2002, National Network of Epidemiological Surveillance Laboratory, Brazil (2002).
14. de Oliveira LH, Danovaro-Holliday MC, Ruiz-Matus C, Andrus JK. Rotavirus vaccine introduction in the Americas: progress and lessons learned. Expert Rev. Vaccines 73(8), 345-353 (2008).
15. Linhares AC, Macias-Parra M, Sáez-Llorens X et al. Rotavirus gastroenteritis in Latin America: a hospital-based study in children under years of age. Trials Vaccinol. 1(1), 36-41 (2012).
16. Siqueira AA, Santelli ACFS, Alencar LR Jr et al. Outbreak of acute gastroenteritis in Young children with death due to rotavirus genotype G9 in Rio Branco, Brazilian Amazon region, 2005. Int. J. Infect. Dis. 14(10), e898-e903 (2010).
17. Pagliusi S, Leite LCC, Datla M et al. Developing countries vaccine manufacturers network: doing good by making high-quality vaccines affordable for all. Vaccine 31(31), 3111-3115 (2013).
18. Luna EJ, Frazatti-Gallina NM, Timenetsky MCST et al. A phase I clinical trial of a new 5-valent rotavirus vaccine. Vaccine 31(7), 1100-1105 (2013).
19. Murphy TV, Gargiullo PM, Massoudi MS et al. Intussusception among infants given an oral rotavirus vaccine. N. Engl. J. Med. 344(20), 564-572 (2001).
20. Patel MM, Lo'pez-Collada VR, Bulho?es MM et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N. Engl. J. Med. 364(24), 2283-2292 (2011).
21. do Carmo GM, Yen C, Cortes J, Siqueira AA et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med. 8(4), e1001024 (2011).
22. Brazilian Ministry of Health [Technical note 193/2012: chance in recommended age for administration of measles-mumps-rubella vaccine and oral rotavirus vaccine from January 2013]. National Immunization Program, Secretariat of Epidemiologic Surveillance, Ministry of Health, Brasília, Brazil (2012).
23. World Health Organization. Rotavirus vaccines WHO position paper-January 2013. Wkly Epidemiol. Rec. 88(5), 49-64 (2013).
24. Correia JB, Patel MM, Nakagomi O et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhoea caused by serotypically-unrelated G2P[4] strains in Brazil. J. Infect. Dis. 201(3), 363-369 (2010).
25. Justino MCA, Linhares AC, Lanzieri TM et al. Effectiveness of the monovalent G1P [8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Bele'm, Brazil. Pediatr. Infect. Dis. J. 30(5), 396-401 (2011).
26. Gurgel RQ, Bohland AN, Vieira SA et al. Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program. Gastroenterology 137(6), 1970-1975 (2009).
27. Vieira SCF, Gurgel RQQ, Kirby A et al. Acute diarrhoea in a community cohort of children who received an oral rotavirus vaccine in Northeast Brazil. Mem. Inst. Oswaldo Cruz 106(3), 330-334 (2011).
28. Linhares AC, Velázquez FR, Pérez-Schael I et al. Efficacy and safety of oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 371(9619), 1181-1189 (2008).
29. Ruiz-Palacios GM, Pe'rez-Schael I, Vela'zquez FR et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med. 354(1), 11-22 (2006).
30. Word Health Organization. Generic Protocol for Monitoring Impact of Rotavirus Vaccination on Gastroenteritis Disease Bruden and Viral Strains. World Health Organization, Geneva, Switzerland (2008).
31. de Palma O, Cruz L, Ramos H et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 340, c2825 (2010).
32. Patel M, Pedreira C, de Oliveira LH et al. Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Pediatrics 130(2), e365-e372 (2012).
33. Linhares AC, Bresee JS. Rotavirus vaccines and vaccination in Latin America. Pan. Am. J. Public Health 8(5), 305-331 (2000).
34. Matthijnssens J, Nakagomi O, Kirkwood CD, Ciarlet M, Desselberger U, Van Ranst M. Group A rotavirus universal mass vaccination: how and to what extent will relative pressure influence prevalence of rotavirus genotypes? Expert Rev. Vaccines 11(11), 1347-1354 (2012).
35. Vesikari T, Karvonen A, Prymula R, Schuster V et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 370(9601), 1757-1763 (2007).
36. Borges AM, Dias e Souza M, Fiaccadori FS, Cardoso DP. Monitoring the circulation of rotavirus among children after the introduction of the Rotarix vaccine in Goiânia, Brazil. Mem. Inst. Oswaldo Cruz 106(4), 499-501 (2011).
37. Centenari C, Gurgel RQ, Bohland AK, Oliveira DMP, Faragher B, Cuevas LE. Rotavirus vaccination in northeast Brazil: a laudable intervention, but can it lead to cost-savings? Vaccine 28(25), 4162-4168 (2010).
38. Gurgel RQ, Ilozue C, Correia JB, Centenari C, Oliveira SMT, Cuevas LE. Impact of rotavirus vaccination on diarrhoea mortality and hospital admissions in Brazil. Trop. Med. Int. Health 16(9), 1180-1184 (2011).
39. Lanzieri TM, Costa I, Shafi FA et al. Trends in hospitalizations from all-cause gastroenteritis in children younger than years of age in Brazil before and after human rotavirus vaccine introduction, 1998-2007. Pediatr. Infect. Dis. J. 29(7), 673-675 (2010).
40. Sa'fadi MA, Berezin EN, Munford V et al. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in Sa?o Paulo, Brazil. Pediatr. Infect. Dis. J. 29(11), 1019-1022 (2010).
41. Lanzieri TM, Linhares AC, Costa I et al. Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil. Int. J. Infect. Dis. 15(3), e206-e210 (2011).
42. Gurgel RQ, Correia JB, Cuevas LE. Effect of rotavirus vaccination on circulating virus strains. Lancet 371(9609), 301-302 (2008).
43. Gurgel RQ, Cuevas LE, Vieira SCF et al. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg. Infect. Dis. 13(10), 1571-1573 (2007).
44. Nakagomi T, Cuevas LE, Gurgel RQ et al. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine. Arch. Virol. 153(3), 591-593 (2008).
45. Lopman BA, Payne DC, Tate JE, Patel MM, Cortese MM, Parashar UD. Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011. Curr. Opin. Virol. 2(4), 434-442 (2012).
46. Carvalho-Costa FA, Volota?o Ede M, de Assis RM et al. Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009. Pediatr. Infect. Dis. J. 30 (Suppl. 1), S35-S41 (2011).
47. O'Ryan M. The ever-changing landscape of rotavirus serotypes. Pediatr. Infect. Dis. J. 28 (Suppl. 3), S60-S62 (2009).
48. Linhares AC, Stupka JA, Ciapponi A et al. Burden and typing of rotavirus group A in Latin America and the Caribbean: systematic review and meta-analysis. Rev. Med. Virol. doi: 10.1002/rmv.682 (2011) (Epub ahead of print).
49. Oliveira A, Mascarenhas JDP, Soares LS et al. Rotavirus serotype distribution in northern Brazil trends over a 27 year period pre and post national vaccine introduction. Trials Vaccinol. 1, 4-9 (2012).
50. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev. Med. Virol. 15(1), 29-56 (2005).
51. Carvalho-Costa FA, Arau'jo IT, de Assis RMS et al. Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brazil. Emerg. Infect. Dis. 15(1), 95-97 (2009).
52. Morillo SG, Luchs A, Cilli A, Costa FF, Carmona RCC, Timenetsky MCST. Characterization of rotavirus strains from day care centers: pre-and post-rotavirus vaccine era. J. Pediatr. (Rio J.) 86(2), 155-158 (2010).
53. Cilli A, Luchs A, Morillo SG, Costa FF, Carmona RCC, Timenetsky MCST. Characterization of rotavirus and norovirus strains: a 6-year study (2004-2009). J. Pediatr. (Rio J.) 87(5), 445-449 (2011).
54. Luchs A, Morillo SG, Ribeiro CD et al. Gastroenteritis outbreak due to G2P[4] rotavirus and GII norovirus at two correctional facilities in Brazil, 2010. J. Clin. Virol. 51(3), 213-214 (2011).
55. Dulgheroff AC, Figueiredo EF, Moreira LP et al. Distribution of rotavirus genotypes after vaccine introduction in the Triângulo Mineiro region of Brazil: 4-year follow-up study. J. Clin. Virol. 55(1), 67-71 (2013).
56. Sa'ez-Llorens X, Vela'zquez FR, Lopez P et al. A multi-country study of intussusception in children under 2 years of age in Latin America: analysis of prospective surveillance data. BMC Gastroenterol. 13, 95 (2013).
57. Peters G, Myers MG. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics 110(6), e67 (2012).
58. Desai R, Parashar UD, Lopman B et al. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America. Clin. Infect. Dis. 54(10), 1397-405 (2012).
59. PATH (2013). http://sites.path.org/rotavirusvaccine/ rotavirus-advocacy- and-communicationstoolkit/ country-introduction-maps-and-list/ (Accessed 30 August 2013)
60. Gurgel. Imunizaçoes. Cobertura por ano e regiao. http://tabnet.datasus.gov.br/cgi/tabcgi.exe? pni/cnv/cpniuf.def (Accessed 30 August 2013)
61. Rissardo LK, Furlan MCR, Marcon SS, Ferrer ALM, Oliveira RG. Hospital morbidity before and after vaccination program against rotavirus in the state of Paraná-Brazil: exploratory-descriptive study. Online Braz. J. Nursing [Internet] 9(2) (2010). http://www.objnursing.uff.br/index.php/ nursing/article/view/3053 (Accessed 11 November 2013)